Shanghai Kinetic Medical Co., Ltd (SHE:300326)
China · Delayed Price · Currency is CNY 6.48
+0.03 (0.47%)
Nov 13, 2026, 3:04 PM CST
Shanghai Kinetic Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 436.15 | 288.42 | 377.11 | 620.44 | 707.49 | 729.03 |
Trading Asset Securities | 1,247 | 1,228 | 841.43 | 421.23 | 264.4 | 177.8 |
Cash & Short-Term Investments | 1,683 | 1,517 | 1,219 | 1,042 | 971.89 | 906.83 |
Cash Growth | 30.28% | 24.46% | 16.98% | 7.18% | 7.17% | 4.68% |
Accounts Receivable | 97.24 | 80.4 | 204.76 | 221.56 | 385.19 | 484.1 |
Other Receivables | 16.18 | 109.58 | 39.67 | 46.56 | 53.92 | 71.62 |
Receivables | 113.42 | 189.98 | 244.43 | 268.12 | 439.12 | 555.72 |
Inventory | 311.15 | 307.73 | 381.81 | 368.42 | 346.83 | 293.6 |
Other Current Assets | 17.84 | 29.98 | 29.21 | 29.78 | 65.71 | 38.25 |
Total Current Assets | 2,125 | 2,044 | 1,874 | 1,708 | 1,824 | 1,794 |
Property, Plant & Equipment | 199.03 | 215.58 | 395.15 | 374.41 | 353.19 | 364.64 |
Long-Term Investments | 146.94 | 184.25 | 267.5 | 492.92 | 467.89 | 421.54 |
Goodwill | 513.87 | 498.89 | 609.67 | 602.17 | 593.79 | 749.98 |
Other Intangible Assets | 95.61 | 42.58 | 52.1 | 54.98 | 59.24 | 63.84 |
Long-Term Deferred Tax Assets | 49.51 | 51.79 | 54.74 | 28.13 | 20.69 | 17.92 |
Long-Term Deferred Charges | 10.63 | 11.77 | 52.85 | 64.38 | 63.57 | 66.16 |
Other Long-Term Assets | 24.19 | 25.06 | 44.86 | 29.02 | 30.24 | 31.18 |
Total Assets | 3,165 | 3,074 | 3,351 | 3,354 | 3,412 | 3,510 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 27.86 | 21.78 | 54.06 | 67.53 | 98.39 | 110.8 |
Accrued Expenses | 19.19 | 43.85 | 78.68 | 76.64 | 95.87 | 89.7 |
Short-Term Debt | 40.01 | 40.01 | 233.62 | 126.44 | 177.38 | 190.9 |
Current Portion of Long-Term Debt | - | - | 4.08 | - | 100.13 | 80.23 |
Current Portion of Leases | 4.64 | 4.84 | 17.96 | 16.71 | 15.89 | 13.07 |
Current Income Taxes Payable | 8.19 | 20.56 | 4.55 | 0.94 | 8.72 | 18.75 |
Current Unearned Revenue | 18.02 | 22.32 | 29.14 | 23.21 | 26.27 | 25.27 |
Other Current Liabilities | 29.59 | 10.55 | 19.14 | 17.91 | 21.99 | 39.17 |
Total Current Liabilities | 147.5 | 163.91 | 441.23 | 329.39 | 544.64 | 567.89 |
Long-Term Debt | - | - | 9.51 | - | - | 100 |
Long-Term Leases | 5.69 | 9.38 | 61.31 | 53.67 | 35.09 | 41.42 |
Long-Term Unearned Revenue | 1.7 | 3.43 | 5.23 | 6.54 | 8.27 | 12.93 |
Long-Term Deferred Tax Liabilities | 14.17 | 4.32 | 14.1 | 15.15 | 8.85 | 9.02 |
Other Long-Term Liabilities | - | - | 0.6 | 0.6 | 0.6 | - |
Total Liabilities | 169.06 | 181.03 | 531.98 | 405.35 | 597.45 | 731.27 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 717.01 | 717.01 | 717.03 | 717.03 | 717.03 | 720.15 |
Additional Paid-In Capital | 724.83 | 724.83 | 695.23 | 699.81 | 703.43 | 730.13 |
Retained Earnings | 1,547 | 1,407 | 1,265 | 1,411 | 1,299 | 1,356 |
Treasury Stock | - | - | -0.14 | -0.14 | -0.14 | -32.01 |
Comprehensive Income & Other | -21.3 | 14.61 | 43.58 | 31.88 | 19.85 | -40.96 |
Total Common Equity | 2,968 | 2,863 | 2,721 | 2,860 | 2,740 | 2,734 |
Minority Interest | 28.33 | 30.04 | 97.96 | 88.81 | 75.13 | 44.86 |
Shareholders' Equity | 2,996 | 2,893 | 2,819 | 2,949 | 2,815 | 2,778 |
Total Liabilities & Equity | 3,165 | 3,074 | 3,351 | 3,354 | 3,412 | 3,510 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 50.34 | 54.22 | 326.48 | 196.83 | 328.49 | 425.62 |
Net Cash (Debt) | 1,632 | 1,462 | 892.06 | 844.84 | 643.41 | 481.21 |
Net Cash Growth | 63.63% | 63.93% | 5.59% | 31.31% | 33.71% | -10.92% |
Net Cash Per Share | 2.28 | 2.04 | 1.24 | 1.18 | 0.89 | 0.67 |
Filing Date Shares Outstanding | 717.01 | 717.01 | 717.01 | 717.01 | 716.37 | 720.13 |
Total Common Shares Outstanding | 717.01 | 717.01 | 717.01 | 717.01 | 716.37 | 720.13 |
Working Capital | 1,978 | 1,880 | 1,433 | 1,379 | 1,279 | 1,227 |
Book Value Per Share | 4.14 | 3.99 | 3.79 | 3.99 | 3.82 | 3.80 |
Tangible Book Value | 2,358 | 2,322 | 2,059 | 2,203 | 2,087 | 1,920 |
Tangible Book Value Per Share | 3.29 | 3.24 | 2.87 | 3.07 | 2.91 | 2.67 |
Buildings | - | 219.14 | 219.14 | 219.14 | 219.24 | - |
Machinery | - | 214.31 | 336.29 | 324.13 | 286.48 | 484.74 |
Construction In Progress | - | - | 33.13 | 1.15 | 11.38 | 10.69 |